A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy ; volume:10 ; number:1 ; day:3 ; month:1 ; year:2017 ; pages:1-11 ; date:12.2017
Journal of hematology & oncology ; 10, Heft 1 (3.1.2017), 1-11, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Zhang, Erhao
- Contributor
-
Xu, Hanmei
SpringerLink (Online service)
- DOI
-
10.1186/s13045-016-0379-6
- URN
-
urn:nbn:de:1111-201701306018
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhang, Erhao
- Xu, Hanmei
- SpringerLink (Online service)
Other Objects (12)
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells
Cellular Immunotherapy for Hematological Disorders : From Allogeneic Stem Cell Transplantation to Chimeric Antigen Receptor-engineered T-cell Application
Therapeutic applications of engineered chimeric antigen receptors-T cell for cancer therapy
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
Glyco-binding domain chimeric antigen receptors as a new option for cancer immunotherapy
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
Genetically engineered antigen-specific treg cells in immunotherapy: opportunities and challenges
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells
Cellular Immunotherapy for Hematological Disorders : From Allogeneic Stem Cell Transplantation to Chimeric Antigen Receptor-engineered T-cell Application
Therapeutic applications of engineered chimeric antigen receptors-T cell for cancer therapy
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
Glyco-binding domain chimeric antigen receptors as a new option for cancer immunotherapy
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
Genetically engineered antigen-specific treg cells in immunotherapy: opportunities and challenges
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells
Cellular Immunotherapy for Hematological Disorders : From Allogeneic Stem Cell Transplantation to Chimeric Antigen Receptor-engineered T-cell Application
Therapeutic applications of engineered chimeric antigen receptors-T cell for cancer therapy
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
Glyco-binding domain chimeric antigen receptors as a new option for cancer immunotherapy
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects